NetworkNewsBreaks – Alkermes plc (NASDAQ: ALKS) Featured in Mizuho Securities Research Report
Alkermes plc (NASDAQ: ALKS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Alkermes announced this morning that the FDA will hold an Advisory Committee Meeting on October 9 to discuss their pipeline drug ALKS 3831. We already knew a meeting was coming up ahead of the November 15 FDA action date and that it would focus on the clinical meaningfulness of the ALKS 3831 data. Importantly, the company also now disclosed that the meeting will discuss ""certain potential clinical risks related to the interaction of ALKS 3831...and opioids in the intended…







